BR112015021456A2 - uso tópico de uma formulação antimicrobiana - Google Patents

uso tópico de uma formulação antimicrobiana

Info

Publication number
BR112015021456A2
BR112015021456A2 BR112015021456A BR112015021456A BR112015021456A2 BR 112015021456 A2 BR112015021456 A2 BR 112015021456A2 BR 112015021456 A BR112015021456 A BR 112015021456A BR 112015021456 A BR112015021456 A BR 112015021456A BR 112015021456 A2 BR112015021456 A2 BR 112015021456A2
Authority
BR
Brazil
Prior art keywords
antimicrobial formulation
phenolic compound
topical use
antimicrobial
body part
Prior art date
Application number
BR112015021456A
Other languages
English (en)
Inventor
Letellier Ann
Lemire Gaetan
Quessy Sylvain
Desranleau Dandurand Ulysse
Original Assignee
Laboratoire M2
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire M2 filed Critical Laboratoire M2
Publication of BR112015021456A2 publication Critical patent/BR112015021456A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/08—Oxygen or sulfur directly attached to an aromatic ring system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/08—Oxygen or sulfur directly attached to an aromatic ring system
    • A01N31/16—Oxygen or sulfur directly attached to an aromatic ring system with two or more oxygen or sulfur atoms directly attached to the same aromatic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Pest Control & Pesticides (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Dispersion Chemistry (AREA)

Abstract

resumo patente de invenção: "uso tópico de uma formulação antimicrobiana". a presente invenção refere-se a um método de redução de uma presença microbiana sobre pelo menos uma parte do corpo de um indivíduo mediante a aplicação tópica à parte do corpo do indivíduo de uma formulação antimicrobiana compreendendo: a) pelo menos um composto fenólico isolado ou sintético antimicrobiano de origem natural, selecionado do grupo que consiste de timol e carvacrol; b) pelo menos um tensoativo suficiente para formar uma solução ou dispersão de dito composto fenólico em um portador aquoso; c) um solvente para dissolver dito composto fenólico; e d) uma quantidade suficiente de portador aquoso para perfazer 100 % (p/p).
BR112015021456A 2013-03-08 2014-03-04 uso tópico de uma formulação antimicrobiana BR112015021456A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/790,911 US9750245B2 (en) 2013-03-08 2013-03-08 Topical use of an antimicrobial formulation
PCT/CA2014/000174 WO2014134709A1 (en) 2013-03-08 2014-03-04 Topical use of an antimicrobial formulation

Publications (1)

Publication Number Publication Date
BR112015021456A2 true BR112015021456A2 (pt) 2017-07-18

Family

ID=51488568

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015021456A BR112015021456A2 (pt) 2013-03-08 2014-03-04 uso tópico de uma formulação antimicrobiana

Country Status (10)

Country Link
US (1) US9750245B2 (pt)
EP (1) EP2964208B1 (pt)
JP (2) JP6055905B2 (pt)
CN (2) CN105555263A (pt)
AU (1) AU2014225230B2 (pt)
BR (1) BR112015021456A2 (pt)
CA (1) CA2927442C (pt)
HK (1) HK1218261A1 (pt)
MX (1) MX363107B (pt)
WO (1) WO2014134709A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190274952A1 (en) * 2013-03-08 2019-09-12 Laboratoire M2 Topical use of an antimicrobial formulation
US10105342B2 (en) 2015-08-05 2018-10-23 Cmpd Licensng, Llc Compositions and methods for treating an infection
US9707229B2 (en) * 2015-12-18 2017-07-18 Cmpd Licensing, Llc Compositions and methods for treating an infection
US10617703B2 (en) 2014-12-10 2020-04-14 Cmpd Licensing, Llc Compositions and methods for treating an infection
US10898455B2 (en) 2016-01-07 2021-01-26 Cmpd Licensing, Llc Urea cream formulations
US11793783B2 (en) 2015-08-05 2023-10-24 Cmpd Licensing, Llc Compositions and methods for treating an infection
US11278590B2 (en) 2015-08-05 2022-03-22 Cmpd Licensing, Llc Compositions and methods for treating nail infections
US10898491B2 (en) 2015-12-18 2021-01-26 Cmpd Licensing, Llc Compositions and methods for treating an infection
US11690815B2 (en) 2015-08-05 2023-07-04 Cmpd Licensing Llc Hyperkeratotic skin condition treatments and compositions
US11684567B2 (en) 2015-08-05 2023-06-27 Cmpd Licensing, Llc Compositions and methods for treating an infection
US11446236B2 (en) * 2015-08-05 2022-09-20 Cmpd Licensing, Llc Topical antimicrobial compositions and methods of formulating the same
EA201891932A1 (ru) * 2016-03-15 2019-03-29 Игорь Поляков Композиции для лечения и предупреждения заболеваний копыт и когтей
CN105830826A (zh) * 2016-05-13 2016-08-10 重庆市璧山区渝璧玉血橙种植股份合作社 一种治疗柑橘脚腐病的方法
GB2571235B (en) 2016-11-09 2021-05-19 Provita Eurotech Ltd Antimicrobial formulations for the treatment of veterinary hoof infections
US10779525B2 (en) 2018-01-16 2020-09-22 Zin Research LLC Treatment compound and method of application for hoof or foot disease in animals
EP3793362A1 (en) * 2018-05-17 2021-03-24 Agro Research International, LLC Herbicide composition for use in killing one or more plant species
CN108815184A (zh) * 2018-06-29 2018-11-16 佛山市南海东方澳龙制药有限公司 动物局部用抗微生物制剂及其应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9901733L (sv) * 1999-05-12 2000-11-13 Akzo Nobel Nv En komposition innehållande karvakrol och tymol för användning som bactericid
US6884763B2 (en) 2001-10-30 2005-04-26 Permatex, Inc. Waterless hand cleaner containing plant derived natural essential oil
US20030225003A1 (en) * 2002-04-18 2003-12-04 Dusan Ninkov Antimicrobial therapeutic compositions for oral and topical use
PT1753529E (pt) 2004-05-20 2013-11-18 Eden Research Plc Composições contendo uma partícula oca de glucano ou uma partícula de parede celular encapsulando um componente de terpeno, e métodos para a sua produção e utilização
US8198326B2 (en) * 2004-09-07 2012-06-12 3M Innovative Properties Company Phenolic antiseptic compositions and methods of use
KR20140103191A (ko) 2005-11-30 2014-08-25 에덴 리서치 피엘씨 티몰, 유게놀, 게라니올, 시트랄, 및 ｌ―카르본에서 선택된 테르펜 또는 테르펜 혼합물을 포함하는 조성물 및 방법
WO2008048963A2 (en) 2006-10-16 2008-04-24 Sergeant's Pet Care Products Inc. Natural compositions for killing parasites on a companion animal
BRPI0911317B1 (pt) * 2008-04-08 2019-06-04 Laboratoire M2 Formulação de solução desinfetante aquosa, seu método de preparação e método de desinfetar uma superfície
US20090258098A1 (en) 2008-04-15 2009-10-15 Lane Rolling Penetrating carrier, antifungal composition using the same and method for treatment of dermatophyte infections
WO2009132343A1 (en) 2008-04-25 2009-10-29 Nanobio Corporation Nanoemulsions for treating onchomycosis
GB0813323D0 (en) 2008-07-21 2008-08-27 Campbell Donald Antimicrobial compositions and methods
KR101632091B1 (ko) * 2008-10-20 2016-06-20 유니레버 엔.브이. 항미생물 조성물
BRPI0920972A8 (pt) 2008-10-30 2019-02-05 Ohso Clean Inc sabonetes antimicrobianos espumáveis
JP2012510469A (ja) * 2008-11-28 2012-05-10 アグロケム インコーポレイテッド 蹄病を治療するための組成物及び方法
US20130034618A1 (en) * 2011-08-04 2013-02-07 Karen Swenholt Compositions for treating the integument

Also Published As

Publication number Publication date
CN112691090A (zh) 2021-04-23
JP2015512918A (ja) 2015-04-30
CA2927442A1 (en) 2014-09-12
MX363107B (es) 2019-03-06
US9750245B2 (en) 2017-09-05
WO2014134709A1 (en) 2014-09-12
EP2964208B1 (en) 2022-01-19
CA2927442C (en) 2017-10-10
EP2964208A1 (en) 2016-01-13
AU2014225230A1 (en) 2015-10-22
MX2015011942A (es) 2016-04-04
CN105555263A (zh) 2016-05-04
HK1218261A1 (zh) 2017-02-10
JP6055905B2 (ja) 2016-12-27
US20140256826A1 (en) 2014-09-11
AU2014225230B2 (en) 2018-02-15
JP2016190859A (ja) 2016-11-10
EP2964208A4 (en) 2016-08-31

Similar Documents

Publication Publication Date Title
BR112015021456A2 (pt) uso tópico de uma formulação antimicrobiana
BR112015019657A2 (pt) composições tópicas e métodos de uso das mesmas
CR20140541A (es) Formulaciones farmacéuticas tópicas no acuosas
BR112015021352A2 (pt) composições antimicrobianas
BR112017004524A2 (pt) pirrolopirimidinas para uso na infecção pelo vírus da gripe
BR112015023498A2 (pt) formulação para uma proteína terapêutica
BR112015020026A2 (pt) dispositivo médico visível por mri
CL2011000135A1 (es) Uso de una fromulacion farmaceutica acuosa que comprende 0,5-10% de terbinafina o una sal de la misma, 2-10% de un fosfolipido y 1-5% de un surfactante, para preparar un medicamento util para tratar una infeccion fungica; formulacion farmaceutica.
BR112016006320A8 (pt) sistema de fixação
BR112015032341A2 (pt) conservação de composições para cuidados pessoais
BR112015001414A2 (pt) composição antideriva
BR112018000187A2 (pt) composto, composição, método, e, uso de um composto ou composição
CL2016000684A1 (es) Coformulaciones de bifentrina con agentes de protección de cultivos encapsulados para uso con fertilizantes líquidos.
BR112012032087A2 (pt) composto, medicamento, e, uso de um composto
CR20160235A (es) Tienopirimidinas como inhibidores mknk1 y mknk2
BR112015030088A2 (pt) aprimoramentos em ou referentes a compostos orgânicos
BR112015024075A2 (pt) compostos de piridinilpirazoloquinolina
CR20160281A (es) Formulaciones de giberelina con baja cantidad de productos químicos orgánicos volátiles
BR112018001486A2 (pt) ?composição de limpeza em barra, processo para preparar a composição, método para reduzir atividade antimicrobiana em uma superfície e uso da composição?
BR112015026840A2 (pt) composto, sal farmaceuticamente aceitável, composição farmacêutica, uso de um composto, e, método prevenir ou tratar hiperfosfatemia
BR112018069109A8 (pt) Composições, composições de revestimento aquosas e métodos para aprimorar a estabilidade de congelamento/descongelamento de composições de revestimento aquosas
BR112018069115A2 (pt) composições, composições de revestimento aquosas e métodos para melhorar a estabilidade de congelamento/descongelamento de composições de revestimento aquosas
BR112013028531A2 (pt) composição inseticida líquida
CL2019002516A1 (es) Composiciones cosméticas para el cuidado de la piel.
BR112015002041A2 (pt) formulação transdérmica contendo inibidores de cox

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements